Gene Testing Study for Lung and Head & Neck Cancer
Part of Cancer, Lungs & breathing clinical trials.
This study analyzes genetic information from blood samples in patients with advanced lung cancer, head and neck cancer, or mesothelioma who are starting chemotherapy and immunotherapy. Understanding your cancer's genetics may help doctors personalize treatment and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Diagnosed with advanced non-small cell lung cancer (stage IIIB–IV without certain gene mutations), small cell lung cancer, head and neck cancer, or mesothelioma
- Planning to start chemotherapy combined with immunotherapy within the next 4 weeks
- Able to give blood samples for genetic research
- No active hepatitis B or C requiring treatment in the past month (HIV patients on stable treatment are OK)
- Not taking high-dose prednisone (more than 10 mg daily)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood and tumor samples from people newly diagnosed with small cell lung cancer to study how genetic markers can predict treatment success and monitor disease over time.
This study collects tissue (and follows patients over time) to better understand the natural course of several types of chest cancers. It may help researchers learn which tests and treatments work best in different cancer types.
This trial tries a more personalized treatment approach for people with locally advanced head and neck cancers by testing their tumor and blood for cancer “genetic” clues. If you may be eligible, you would have fresh tumor (and possibly lymph node) biopsies at the start and again if the cancer returns, plus blood tests to guide research and future study options.
This study looks at genetic markers in two types of lung cancer (small cell and large cell neuroendocrine) to understand why some tumors stop responding to a standard treatment that combines chemotherapy with immunotherapy. If you have one of these cancers and are about to start this treatment, you may be able to join.
This study collects and analyzes lung cancer tissue samples to understand genetic differences that may help guide future treatment. You'll provide a tissue sample (either from a biopsy or prior surgery), and researchers will study it—no treatment is given in this study.
This trial uses advanced gene sequencing technology on blood and tumor tissue samples from people with non-small cell lung cancer. The goal is to see if this testing can help doctors better predict which treatments will work and detect if the cancer comes back early.
Hear when a new Small Cell Lung Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.